Systems and methods for the treatment of pain through neural fiber stimulation

Patent metadata

Field	Value
Publication number	US-9855427-B2
Application number	US-201715453978-A
Country	US
Kind code	B2
Filing date	Mar 9, 2017
Priority date	Nov 11, 2010
Publication date	Jan 2, 2018
Grant date	Jan 2, 2018

Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

First claim

Having thus described the invention, we claim:

1. A method of reducing a perception of pain, the method comprising the steps of:
percutaneously inserting a single contact electrode operatively coupled with a lead in-vivo in a patient a therapeutically effective distance from a target efferent nerve fiber;
electrically stimulating through the lead and electrode the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in a small sensory nerve fiber to generate a reduction of pain in the patient.

2. The method of claim 1 , wherein the therapeutically effective distance is 1 mm from the target afferent nerve fiber.

3. The method of claim 1 , wherein the target efferent nerve fiber is located between a neurological motor point and the central nervous system of the patient.

4. The method of claim 1 , wherein the generation of action potentials in the small sensory nerve fiber comprises generation of action potentials in Type III and Type IV nerve fibers.

5. The method of claim 1 , wherein the target efferent nerve fibers comprise motor axons.

6. The method of claim 5 , wherein the motor axons comprise Act axons.

7. The method of claim 1 , wherein the target efferent nerve fiber is located within a region of pain.

8. The method of claim 1 , wherein the target efferent nerve fiber is located outside of a region of pain.

9. A method of reducing a perception of pain, the method comprising the steps of:
percutaneously inserting a lead into a patient, the lead having an electrode extending therefrom, wherein the electrode is positioned at a therapeutically effective distance from a target motor axon;
electrically stimulating through the electrode the target motor axon to generate an action potential in the target motor axon while avoiding generation of action potentials in Type III and Type IV afferent nerve fibers; and
removing the lead and electrode, wherein pain relief is generally maintained for a time after the removal.

10. The method of claim 9 , wherein the electrode is a single contact electrode.

11. The method of claim 9 , wherein the electrical stimulation relieves pain.

12. The method of claim 9 , wherein the time is two weeks.

13. The method of claim 9 , wherein the motor axon comprises an Aα axon.

14. The method of claim 9 , wherein the motor axon comprises an Aγ axon.

15. A method of reducing a perception of pain, the method comprising:
percutaneously inserting a lead having a single contact electrode into a patient; and
electrically stimulating through the single contact electrode inserted in-vivo by an electrical stimulator a plurality of target efferent motor nerve fibers to generate an action potential in the plurality of target efferent motor nerve fibers while avoiding generation of action potentials in small sensory nerve fibers.

16. The method of claim 15 , wherein the small sensory nerve fibers include Type III and IV nerve fibers.

17. The method of claim 15 , wherein the electrode is inserted a therapeutically effective distance from the target efferent motor nerve fibers, whereby the therapeutically effective distance is 1 mm from the target efferent motor nerve fibers.

18. The method of claim 15 , wherein generating the action potential in the plurality of target efferent motor nerve fibers causes a contraction of muscle.

19. The method of claim 18 , wherein the contraction of muscle reduces the perception of pain.

20. A system to reduce a perception of pain, the system comprising:
a lead;
a single contact electrode operatively coupled with the lead, the electrode percutaneously inserted into a patient; and
an electrical stimulator operatively coupled with the lead, the electrical stimulator electrically stimulating through the single contact electrode a plurality of target efferent motor nerve fibers to generate an action potential in the plurality of target efferent motor nerve fibers while avoiding generation of action potentials in small sensory nerve fibers.

21. The system of claim 20 , wherein generation of action potentials in the small sensory nerve fibers causes contraction of muscle.

22. The system of claim 21 , wherein the contraction of muscle reduces the perception of pain.

23. A system to reduce a perception of pain, the system comprising:
a percutaneous lead;
a single contact electrode operatively coupled with the percutaneous lead, the electrode placed in at least one of muscle, subcutaneous, connective or adipose tissue located near a nerve trunk upstream from a region of pain;
an electrical stimulator operatively coupled with the lead, the electrical stimulator electrically stimulating through the single contact electrode a plurality of target efferent motor nerve fibers to generate an action potential in the plurality of target efferent motor nerve fibers while avoiding generation of action potentials in small sensory nerve fibers.

Assignees

• Spr Therapeutics Llc
• Spr Therapeutics Inc

Inventors

• Bennett Maria E
• Boggs Joseph W
• Grill Warren M
• Chae John

Classifications

• A61N1/36071 Primary

  Pain · CPC title

• A61N1/36021

  for treatment of pain · CPC title

• A61N1/36057

  adapted for stimulating afferent nerves · CPC title

• A61N1/36017

  with leads or electrodes penetrating the skin · CPC title

• A61N1/36003

  of motor muscles, e.g. for walking assistance · CPC title